Results 141 to 150 of about 51,607 (296)

What is your diagnosis? Abnormal cluster on the WDF and WNR scattergrams from Sysmex XN‐V in a dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Theo Chenal   +3 more
wiley   +1 more source

Tailored Therapeutic Approach in a Patient With Diffuse Large B‐Cell Lymphoma With Meningeal Infiltration, Concurrent Classic Hodgkin Lymphoma, and Smoldering Multiple Myeloma: A Case Report

open access: yesCancer Reports, Volume 8, Issue 4, April 2025.
ABSTRACT Background Coexisting primary hematologic malignancies in untreated multiple myeloma (MM) are rare. Case A 69‐year‐old man with smoldering multiple myeloma (sMM) presented with lymphadenopathies and an intracranial mass. He was diagnosed with diffuse large B‐cell lymphoma (DLBCL), classic Hodgkin lymphoma (cHL), and sMM. The patient received R‐
Giusy Ceparano   +5 more
wiley   +1 more source

Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia [PDF]

open access: bronze, 1999
Martin S. Tallman   +6 more
openalex   +1 more source

Drug Sensitivity patterns across FAB subtypes and molecular mutations in AML: A comprehensive analysis for precision medicine

open access: yesClinical and Translational Discovery, Volume 5, Issue 2, April 2025.
The study revealed distinct drug sensitivity patterns across acute myeloid leukaemia (AML) French–American–British (FAB) subtypes and mutations. The findings underscore the importance of integrating FAB classifications and mutation profiles in treatment decisions.
Mobina Shrestha   +4 more
wiley   +1 more source

No impact of high‐dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission [PDF]

open access: bronze, 2000
Jean‐Yves Cahn   +12 more
openalex   +1 more source

Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine [PDF]

open access: bronze, 2000
David Sternberg   +6 more
openalex   +1 more source

Central nervous system relapse of primary cutaneous anaplastic large cell lymphoma: A case report

open access: yeseJHaem, Volume 6, Issue 2, April 2025.
Abstract Primary cutaneous anaplastic large cell lymphoma (PC‐ALCL) has a high relapse rate. However, it typically remains confined to the skin and has a favorable long‐term prognosis. We describe a case of PC‐ALCL that experienced a relapse in the central nervous system (CNS).
Satoshi Mitsuyuki   +7 more
wiley   +1 more source

Sequential high‐dose methotrexate and cytarabine administration improves outcomes in real‐world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance

open access: yeseJHaem
Background Despite recent advances, optimal therapeutic approaches applicable to subpopulations with primary central nervous system (CNS) lymphoma outside of clinical trials remain to be determined.
Maciej Tatarczuch   +26 more
doaj   +1 more source

Varicella-Zoster Virus and Subcutaneous Cytarabine: Correlation of In Vitro Sensitivities to Blood Levels

open access: green, 1975
Dawlat A. Zaky   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy